Sana Biotechnology annual total assets
2020
2021
2022
2023
2024
2025
Sana Biotechnology Total Assets Growth & History (SANA)
Sana Biotechnology's total assets was $416.9M for fiscal 2025.
View full Sana Biotechnology company overviewSana Biotechnology annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $416.9M | −$84.1M | −16.79% |
| 2024 | 2024-12-31 | $501.0M | −$64.3M | −11.37% |
| 2023 | 2023-12-31 | $565.3M | −$257.4M | −31.29% |
| 2022 | 2022-12-31 | $822.7M | −$306.7M | −27.15% |
| 2021 | 2021-12-31 | $1.13B | $399.1M | +54.65% |
| 2020 | 2020-12-31 | $730.3M | — | — |
Sana Biotechnology quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $431.5M | $69.9M | +19.32% |
| Q1 2026 | 2026-03-31 | $373.6M | −$71.9M | −16.14% |
| Q4 2025 | 2025-12-31 | $416.9M | −$84.1M | −16.79% |
| Q3 2025 | 2025-09-30 | $435.4M | −$124.0M | −22.16% |
| Q2 2025 | 2025-06-30 | $361.6M | −$257.0M | −41.54% |
| Q1 2025 | 2025-03-31 | $445.5M | −$235.9M | −34.62% |
| Q4 2024 | 2024-12-31 | $501.0M | −$64.3M | −11.37% |
| Q3 2024 | 2024-09-30 | $559.4M | −$72.0M | −11.41% |
| Q2 2024 | 2024-06-30 | $618.7M | −$88.5M | −12.51% |
| Q1 2024 | 2024-03-31 | $681.4M | −$65.6M | −8.78% |
| Q4 2023 | 2023-12-31 | $565.3M | −$257.4M | −31.29% |
| Q3 2023 | 2023-09-30 | $631.4M | −$266.7M | −29.69% |
| Q2 2023 | 2023-06-30 | $707.1M | −$263.9M | −27.18% |
| Q1 2023 | 2023-03-31 | $746.9M | −$300.7M | −28.70% |
| Q4 2022 | 2022-12-31 | $822.7M | −$306.7M | −27.15% |
| Q3 2022 | 2022-09-30 | $898.1M | −$334.6M | −27.15% |
| Q2 2022 | 2022-06-30 | $971.1M | −$288.7M | −22.92% |
| Q1 2022 | 2022-03-31 | $1.05B | −$256.9M | −19.69% |
| Q4 2021 | 2021-12-31 | $1.13B | $399.1M | +54.65% |
| Q3 2021 | 2021-09-30 | $1.23B | — | — |
| Q2 2021 | 2021-06-30 | $1.26B | — | — |
| Q1 2021 | 2021-03-31 | $1.30B | — | — |
| Q4 2020 | 2020-12-31 | $730.3M | — | — |
Sana Biotechnology total assets trends
Over the last five fiscal years, Sana Biotechnology's total assets decreased from $730.3M to $416.9M, a change of −$313.4M. The latest reported quarter, Q2 2026, shows $431.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sana Biotechnology source filings ↗